 |
Previous Article | Next Article 
The Journal of Neuroscience, July 1, 1998, 18(13):5086-5094
Small Changes in Ambient Temperature Cause Large Changes in
3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin
Neurotoxicity and Core Body Temperature in the Rat
Jessica E.
Malberg and
Lewis S.
Seiden
University of Chicago, Department of Pharmacological and
Physiological Sciences, Chicago, Illinois 60637
The amphetamine derivative 3,4-methylenedioxymethamphetamine
(MDMA) is a drug of abuse and has been shown to be neurotoxic to 5-HT
terminals in many species. MDMA-engendered neurotoxicity has been shown
to be affected by both ambient temperature and core body temperature.
We now report that small (2°C) changes in ambient temperature produce
changes in core temperature in MDMA-treated rats, but the same changes
in ambient temperature do not affect core temperature of saline-treated
animals. Furthermore, increases in core temperature of MDMA-treated
animals increase neurotoxicity. Rats were given MDMA (20 or 40 mg/kg)
or saline and placed in an ambient temperature of 20, 22, 24, 26, 28, or 30°C using a novel temperature measurement apparatus that controls ambient temperature ±0.5°C. Two weeks after MDMA treatment, the rats
were killed, and regional 5-HT and 5-hydroxyindole acetic acid levels
were analyzed as a measure of neurotoxicity. Rats treated with MDMA at
20 and 22°C showed a hypothermic core temperature response. Treatment
with MDMA at 28 and 30°C produced a hyperthermic response. At ambient
temperatures of 20-24°C, neurotoxicity was not observed in the
frontal cortex, somatosensory cortex, hippocampus, or striatum. At
ambient temperatures of 26-30°C, neurotoxicity was seen and
correlated with core temperature in all regions examined. These data
indicate that ambient temperature has a significant affect on MDMA
neurotoxicity, core temperature, and thermoregulation in rats. This
finding has implications on both the temperature dependence of the
mechanism of MDMA neurotoxicity and human use because fatal
hyperthermia is associated with MDMA use in humans.
Key words:
MDMA; amphetamine; core body temperature; ambient
temperature; neurotoxicity; 5-HT; thermoregulation
Copyright © 1998 Society for Neuroscience 0270-6474/98/18135086-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. Mueller, J. Yuan, A. Felim, A. Neudorffer, F. T. Peters, H. H. Maurer, U. D. McCann, M. Largeron, and G. A. Ricaurte
Further Studies on the Role of Metabolites in ({+/-})-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity
Drug Metab. Dispos.,
October 1, 2009;
37(10):
2079 - 2086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Green, C. Marsden, and K. Fone
MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt
J Psychopharmacol,
November 1, 2008;
22(8):
929 - 931.
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Rusyniak, M. V. Zaretskaia, D. V. Zaretsky, and J. A. DiMicco
3,4-Methylenedioxymethamphetamine- and 8-Hydroxy-2-di-n-propylamino-tetralin-Induced Hypothermia: Role and Location of 5-Hydroxytryptamine 1A Receptors
J. Pharmacol. Exp. Ther.,
November 1, 2007;
323(2):
477 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Banks, J. E. Sprague, D. F. Kisor, P. W. Czoty, D. E. Nichols, and M. A. Nader
Ambient Temperature Effects on 3,4-Methylenedioxymethamphetamine-Induced Thermodysregulation and Pharmacokinetics in Male Monkeys
Drug Metab. Dispos.,
October 1, 2007;
35(10):
1840 - 1845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Alves, T. Summavielle, C. J. Alves, J. Gomes-da-Silva, J. C. Barata, E. Fernandes, M. de Lourdes Bastos, M. A. Tavares, and F. Carvalho
Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria
J. Neurosci.,
September 19, 2007;
27(38):
10203 - 10210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sessa
Is there a case for MDMA-assisted psychotherapy in the UK?
J Psychopharmacol,
March 1, 2007;
21(2):
220 - 224.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Piper, H. L. Vu, M. G. Safain, A. J. Oliver, and J. S. Meyer
Repeated Adolescent 3,4-Methylenedioxymethamphetamine (MDMA) Exposure in Rats Attenuates the Effects of a Subsequent Challenge with MDMA or a 5-Hydroxytryptamine1A Receptor Agonist
J. Pharmacol. Exp. Ther.,
May 1, 2006;
317(2):
838 - 849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Parrott
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress
J Psychopharmacol,
March 1, 2006;
20(2):
147 - 163.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Easton and C. A. Marsden
Ecstasy: Are animal data consistent between species and can they translate to humans?
J Psychopharmacol,
March 1, 2006;
20(2):
194 - 210.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Arnone, F. Schifano, and B. Sessa
Psychedelics in psychiatry * Author's reply:
The British Journal of Psychiatry,
January 1, 2006;
188(1):
88 - 89.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Jones, C. Duvauchelle, A. Ikegami, C. M. Olsen, S. S. Lau, R. de la Torre, and T. J. Monks
Serotonergic Neurotoxic Metabolites of Ecstasy Identified in Rat Brain
J. Pharmacol. Exp. Ther.,
April 1, 2005;
313(1):
422 - 431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Darvesh, B. K. Yamamoto, and G. A. Gudelsky
Evidence for the Involvement of Nitric Oxide in 3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletion in the Rat Brain
J. Pharmacol. Exp. Ther.,
February 1, 2005;
312(2):
694 - 701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Parrott
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
J Psychopharmacol,
January 1, 2005;
19(1):
71 - 83.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Sanchez, E. O'shea, K. S. Saadat, J. M. Elliott, M. I. Colado, and A. R. Green
Effect of Repeated ('Binge') Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones
J Psychopharmacol,
September 1, 2004;
18(3):
412 - 416.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Green, A. O. Mechan, J. M. Elliott, E. O'Shea, and M. I. Colado
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
Pharmacol. Rev.,
September 1, 2003;
55(3):
463 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Sprague, M. L. Banks, V. J. Cook, and E. M. Mills
Hypothalamic-Pituitary-Thyroid Axis and Sympathetic Nervous System Involvement in Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy)
J. Pharmacol. Exp. Ther.,
April 1, 2003;
305(1):
159 - 166.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. C. Nicholas and L. S. Seiden
Ambient Temperature Influences Core Body Temperature Response in Rat Lines Bred for Differences in Sensitivity to 8-Hydroxy-dipropylaminotetralin
J. Pharmacol. Exp. Ther.,
April 1, 2003;
305(1):
368 - 374.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. A. Ricaurte, J. Yuan, G. Hatzidimitriou, B. J. Cord, and U. D. McCann
Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")
Science,
September 27, 2002;
297(5590):
2260 - 2263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Reneman, C. B. L. M. Majoie, H. Flick, and G. J. den Heeten
Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
AJNR Am. J. Neuroradiol.,
February 1, 2002;
23(2):
231 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Pedersen and W. W. Blessing
Cutaneous Vasoconstriction Contributes to Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) in Conscious Rabbits
J. Neurosci.,
November 1, 2001;
21(21):
8648 - 8654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kalant
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs
Can. Med. Assoc. J.,
October 1, 2001;
165(7):
917 - 928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Lester, M. Baggott, S. Welm, N. B. Schiller, R. T. Jones, E. Foster, and J. Mendelson
Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial
Ann Intern Med,
December 19, 2000;
133(12):
969 - 973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Xie, U. D. McCann, S. Kim, J. Yuan, and G. A. Ricaurte
Effect of Temperature on Dopamine Transporter Function and Intracellular Accumulation of Methamphetamine: Implications for Methamphetamine-Induced Dopaminergic Neurotoxicity
J. Neurosci.,
October 15, 2000;
20(20):
7838 - 7845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Sabol, J. B. Richards, and K. Yung
The Effects of High-Dose Methamphetamine in the Aging Rat: Differential Reinforcement of Low-Rate 72-s Schedule Behavior and Neurochemistry
J. Pharmacol. Exp. Ther.,
September 1, 2000;
294(3):
850 - 863.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Allan, L. C. Parker, B. Collins, R. Davies, G. N. Luheshi, and N. J. Rothwell
Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat
PNAS,
May 9, 2000;
97(10):
5580 - 5585.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|